Viewing nowEsomedin 40mg Tablets (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

MFDS item code 201907454 · Approved 2019.10.25 · Insurance code 649702360
Treatment and prevention of gastroesophageal reflux, Zollinger-Ellison syndrome, eradication therapy, ulcers, rebleeding, and gastrointestinal disorders caused by anti-inflammatory analgesics
This medication is used for the treatment of gastroesophageal reflux disease and erosive reflux esophagitis, and is effective for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It also helps relieve symptoms in patients with gastroesophageal reflux disease without esophagitis. It is also used in combination with antibiotics for the eradication of Helicobacter pylori during treatment of duodenal ulcers and peptic ulcers and contributes to preventing recurrence. It is effective in the short-term management of upper gastrointestinal symptoms associated with the use of non-steroidal anti-inflammatory drugs (both non-selective and selective COX-2). Additionally, it assists in the treatment of gastric ulcers in patients undergoing continuous non-steroidal anti-inflammatory drug therapy and helps prevent gastric and duodenal ulcers. It is also used in the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding of gastric or duodenal ulcers after intravenous injection. Thus, it is widely utilized in the treatment and prevention of various gastrointestinal diseases.
Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for another 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers associated with NSAID use. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. 4) Patients requiring continuous NSAID treatment - Treatment of gastric ulcers associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following initiation of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection Administer 40 mg once daily for 4 weeks following initiation of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection. Renal impairment No dose adjustment is necessary. Use with caution because experience in patients with severe renal impairment is limited. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. Elderly No dose adjustment is necessary.
Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for another 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers associated with NSAID use. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be used in patients with allergies or a history of hypersensitivity to specific ingredients. It is safest for pregnant or breastfeeding women to avoid taking this medication. Patients with heart disease or a history of myocardial infarction should use this medication cautiously. If this medication is taken for an extended period, it is important to perform regular check-ups to monitor health status. Various side effects such as headache, dizziness, abdominal pain, diarrhea, and skin rash may occur during treatment, so if any unusual symptoms appear, consult a doctor immediately. This medication may interact with other drugs, so be sure to inform your healthcare provider of any medications you are currently taking. Particularly, caution should be exercised when used in combination with antibiotics, antiviral agents, and anticoagulants. This medication reduces gastric acid secretion, which may increase the risk of bacterial overgrowth in the stomach, so it is advisable to inform your healthcare provider if diarrhea persists. Long-term use may increase the risk of osteoporotic fractures, thus periodic checks are necessary for patients with bone density issues. If symptoms such as muscle pain, weakness, or arrhythmias occur while taking this medication, treatment should be stopped immediately, and medical advice should be sought. This medication may exacerbate certain autoimmune conditions, so if symptoms such as skin rash or joint pain appear, consult with your healthcare provider. In case of overdose, as there are no specific antidotes, appropriate treatment according to symptoms should be carried out, and it should be stored in a safe place out of the reach of children.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, sensory disturbance, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, pruritus, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized exanthematous pustulosis, eosinophilia, drug reaction with systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, arthritis exacerbation, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid myalgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, migraine exacerbation, sleep disorders, tremors, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, asthma exacerbation, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, pruritus ani, erythematous rash, papular rash, otitis media, olfactory disturbance, loss of taste, taste aversion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp, nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric mucosal polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it is best to store the medication at room temperature between 1°C and 30°C. Proper storage helps maintain the medication's effectiveness safely.
Pink round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.